Bridge Therapy: Clinical Trials

4 trials of Bridge Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn, 1 completed, 1 not yet recruiting. 2 Phase 1, 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 12Not yet recruiting 1, Withdrawn 1
Not applicable1Withdrawn 1
Phase 41Completed 1

Follow Bridge Therapy: new trials by email Literature Review of Bridge Therapy trials Research Report on Bridge Therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 1Not yet recruitingCity of Hope Medical Center162027-04-172026-08-11
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer
Bendamustine, Biopsy, Biospecimen Collection - Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma
Phase 1WithdrawnFred Hutchinson Cancer Center2025-04-152025-04-01
Mitigation of Emergence Agitation Through Implementation of Masimo Bridge Therapy
Bridge Therapy, Sham Therapy - Emergence Delirium, Agitation, Emergence
Not applicableWithdrawnUniversity of Washington2024-08-272024-10-16
Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency
Symptomatic drugs, Bridge therapy, Mindfulness program - Migraine, Hemicrania
Phase 4CompletedFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta252020-06-152025-01-23

Conditions studied

Burkitt Lymphoma (1)  ·  Emergence Delirium (1)  ·  Migraine Disorders (1)  ·  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Prostatic Neoplasms (1)

Sponsors

City of Hope Medical Center (1)  ·  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1)  ·  Fred Hutchinson Cancer Center (1)  ·  University of Washington (1)

Countries

United States (2)  ·  Italy (1)

Top investigators

Ibrahim Aldoss (1)  ·  Jeffrey Kirsch, MD (1)  ·  Michael Schweizer (1)

NIH funding

P30CA033572 (1)